Jinghua Pharmaceutical Group Co., Ltd. (SHE:002349)

SHE:002349 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	995.48	1,014	921.76	933.27	651.59	581.32
Trading Asset Securities	187.93	105.16	317.7	124.95	213.36	114.74
Cash & Short-Term Investments	1,183	1,119	1,239	1,058	864.95	696.06
Cash Growth	-6.00%	-9.74%	17.13%	22.35%	24.26%	106.91%
Accounts Receivable	426.77	414.58	387.67	339.16	355.87	367.25
Other Receivables	2.59	2.68	0.68	2.7	17.19	22.56
Receivables	429.37	417.26	388.35	341.86	373.06	389.81
Inventory	272.42	270.35	290.94	307.65	323.12	307.78
Other Current Assets	44.53	37.95	67.06	21.31	33.93	27
Total Current Assets	1,930	1,844	1,986	1,729	1,595	1,421
Property, Plant & Equipment	606.98	616.38	663.36	708.42	1,169	1,211
Long-Term Investments	-	356.99	40.02	46.97	20.99	100.77
Goodwill	167.94	167.94	167.94	167.94	167.94	167.94
Other Intangible Assets	60.25	60.52	62.53	65.06	123.24	123.17
Long-Term Deferred Tax Assets	5.91	5.98	6.22	12.59	14.88	17.46
Long-Term Deferred Charges	-	-	-	-	37.92	41.28
Other Long-Term Assets	605.08	249.67	259.13	267.89	25.01	30.18
Total Assets	3,376	3,302	3,185	3,042	3,198	3,156
Accounts Payable	165.41	148.44	141.94	139.61	213.06	180.61
Accrued Expenses	51.06	115.71	123.65	140.77	107.69	89.29
Short-Term Debt	10.01	10.43	20.92	21.03	68.78	76.57
Current Portion of Long-Term Debt	-	-	-	-	120.16	-
Current Portion of Leases	0.34	0.75	1.18	0.68	1.77	-
Current Income Taxes Payable	26.21	11.16	13.6	12.04	7.95	6.68
Current Unearned Revenue	12.66	11.44	13.6	45.1	30.43	16.29
Other Current Liabilities	60.03	27.65	46.62	35.41	53.39	159.05
Total Current Liabilities	325.72	325.58	361.51	394.63	603.24	528.48
Long-Term Debt	-	-	-	-	-	120
Long-Term Leases	0.24	0.2	0.43	0.91	3.88	-
Long-Term Unearned Revenue	11.52	11.73	10.84	10.65	9.5	10.58
Long-Term Deferred Tax Liabilities	7.55	7.15	7.96	12.02	11.93	10.23
Total Liabilities	345.05	344.66	380.75	418.22	628.54	669.29
Common Stock	814.18	814.18	814.18	814.18	835.72	835.72
Additional Paid-In Capital	769	769	769	905.92	1,017	1,017
Retained Earnings	1,057	995.01	860.5	677.94	514.59	387.27
Treasury Stock	-	-	-	-	-132.2	-132.2
Comprehensive Income & Other	6.89	5.3	0.91	2.89	1.14	0.13
Total Common Equity	2,647	2,583	2,445	2,401	2,236	2,108
Minority Interest	383.54	373.63	359.67	222.77	333.72	379.23
Shareholders' Equity	3,031	2,957	2,804	2,624	2,570	2,487
Total Liabilities & Equity	3,376	3,302	3,185	3,042	3,198	3,156
Total Debt	10.59	11.38	22.54	22.62	194.59	196.57
Net Cash (Debt)	1,173	1,107	1,217	1,036	670.36	499.49
Net Cash Growth	-5.13%	-9.00%	17.51%	54.48%	34.21%	-
Net Cash Per Share	1.44	1.36	1.49	1.27	0.82	0.61
Filing Date Shares Outstanding	814.18	814.18	814.18	814.18	814.18	814.18
Total Common Shares Outstanding	814.18	814.18	814.18	814.18	814.18	814.18
Working Capital	1,604	1,519	1,624	1,334	991.83	892.17
Book Value Per Share	3.25	3.17	3.00	2.95	2.75	2.59
Tangible Book Value	2,419	2,355	2,214	2,168	1,945	1,816
Tangible Book Value Per Share	2.97	2.89	2.72	2.66	2.39	2.23
Buildings	-	575	570.97	567.6	949.94	743.33
Machinery	-	638.6	618.06	619.1	695.42	649.6
Construction In Progress	-	53.57	69.42	61.51	59.36	273.69

Source: S&P Global Market Intelligence. Standard template. Financial Sources.